PAYX AI Stock Analysis – Buy, Hold, or Avoid?
Paychex, Inc. (PAYX)
Paychex (PAYX) is fundamentally strong with resilient margins and a sticky recurring revenue model, but faces near-term growth and technical headwinds as it trades at 52-week lows. While valuation is now fair to attractive versus history, sentiment and technicals remain cautious, suggesting a wait-and-see approach for new capital. The stock is best suited for income or defensive investors seeking stability, but lacks a near-term catalyst for upside.
Fundamentals
Paychex (PAYX) has been a consistent performer in the business services sector, leveraging its established market presence in payroll and HR outsourcing. While shares have come under recent pressure—now at their 52-week low—the company's operational fundamentals, profitability metrics, and recurring revenue base provide a degree of resilience despite potential cyclical headwinds.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
19.87% YoY
Q1 2026
Net Income
7.90% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.8B | 1.6B | 1.5B | 1.4B | 1.5B | 1.3B | 1.3B | 1.3B |
| Revenue Growth YoY | +19.87% | +18.28% | +16.80% | +10.21% | +4.84% | +4.69% | +2.53% | +5.33% |
| Net Income | 560.3M | 395.4M | 383.8M | 297.2M | 519.3M | 413.4M | 427.4M | 379.9M |
| Net Income Growth YoY | +7.90% | -4.35% | -10.20% | -21.77% | +4.15% | +5.27% | +1.96% | +8.42% |
| EPS | $1.56 | $1.10 | $1.07 | $0.82 | $1.44 | $1.15 | $1.19 | $1.06 |
| EPS Growth YoY | +8.33% | -4.35% | -10.08% | -22.64% | +3.60% | +5.50% | +2.59% | +9.28% |
Profitability Metrics
Gross Margin
TTM
Operating Margin
TTM
Net Margin
TTM
Return on Equity
TTM
Return on Assets
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.16% | 73.54% | 73.13% | 72.40% | 74.33% | 71.21% | 71.18% | 71.03% |
| Operating Margin | 43.78% | 36.72% | 35.19% | 30.20% | 45.84% | 40.86% | 41.46% | 37.20% |
| Net Margin | 30.97% | 25.39% | 24.92% | 20.82% | 34.41% | 31.39% | 32.42% | 29.33% |
| Return on Equity (ROE) | 13.96% | 10.19% | 9.67% | 7.20% | 12.61% | 10.53% | 11.10% | 9.99% |
| Return on Assets (ROA) | 4.99% | 3.88% | 3.74% | 2.94% | 5.66% | 4.87% | 5.08% | 4.57% |
Technical Analysis
Unable to retrieve the latest technical indicators for PAYX due to data access issues. Based on available price information and market context, PAYX is near its 52-week low, suggesting bearish pressure and potential for a consolidation phase.
No extreme reading
Price in downtrend
Range-bound market
50 below 200 - bearish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Paychex (PAYX) has been a consistent performer in the business services sector, leveraging its established market presence in payroll and HR outsourcing. While shares have come under recent pressure—now at their 52-week low—the company's operational fundamentals, profitability metrics, and recurring revenue base provide a degree of resilience despite potential cyclical headwinds.
Latest Earnings
Q1 2026 Earnings (Feb 28, 2026)
Earnings Per Share (EPS)
Actual
$1.71
Estimated
$1.67
Surprise
+$0.04
Surprise %
+2.40%
Revenue
Actual
$1.81B
Estimated
$1.78B
Surprise
+$26.7M
Surprise %
+1.50%
Historical Earnings
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $1.71 | $1.26 | $1.22 | $1.19 | $1.49 | $1.14 | $1.16 | $1.12 |
| EPS (Estimated) | $1.67 | $1.23 | $1.20 | $1.19 | $1.48 | $1.13 | $1.14 | $1.10 |
| EPS Surprise | +$0.04 | +$0.03 | +$0.02 | +$0.00 | +$0.01 | +$0.01 | +$0.02 | +$0.02 |
| % Diff | +2.4% | +2.4% | +1.7% | +0.0% | +0.7% | +0.9% | +1.8% | +1.8% |
| Revenue | ||||||||
| Revenue (Actual) | $1.81B | $1.56B | $1.54B | $1.43B | $1.51B | $1.32B | $1.32B | $1.3B |
| Revenue (Estimated) | $1.78B | $1.55B | $1.54B | $1.44B | $1.51B | $1.31B | $1.31B | $1.29B |
| Revenue Surprise | +$26.7M | +$4.31M | +$1.59M | -$15.55M | +$183.84K | +$3.81M | +$4.44M | +$1.62M |
| % Diff | +1.5% | +0.3% | +0.1% | -1.1% | +0.0% | +0.3% | +0.3% | +0.1% |
Valuation
Paychex (PAYX) currently trades at a valuation level below its historical P/E average and peers, indicating potential undervaluation despite recent share price weakness. The company benefits from strong profitability and solid business fundamentals, but growth concerns and subdued near-term outlook have tempered market sentiment. Overall, the valuation suggests a cautious but opportunistic stance given its financial health and growth potential.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 15.02 | 25.14 | 32.71 | 47.86 | 26.29 | 31.84 | 27.64 | 28.47 |
| Price to Sales | 18.61 | 25.53 | 32.61 | 39.86 | 36.19 | 39.99 | 35.83 | 33.40 |
| Price to Book | 8.39 | 10.25 | 12.65 | 13.78 | 13.27 | 13.41 | 12.27 | 11.38 |
| Enterprise Value to EBITDA | 40.84 | 62.00 | 80.64 | 111.92 | 71.74 | 87.94 | 77.02 | 80.88 |
| Enterprise Value to Revenue | 20.39 | 27.77 | 35.35 | 42.24 | 35.73 | 39.73 | 35.38 | 32.94 |
Sentiment & Analyst Ratings
Paychex (PAYX) sentiment is mixed, with analysts predominantly issuing hold or reduce ratings amid cautious expectations for near-term growth. Recent earnings beat estimates, but stock price pressure and downward price target revisions reflect concerns about sales momentum and competitive risks. Social media and retail sentiment lean toward caution, and while some longer-term optimism remains, investors are closely watching margin impacts and macroeconomic headwinds.
Analyst Recommendations
Risk Assessment
Paychex (PAYX) currently exhibits moderate financial risk characterized by adequate liquidity but elevated leverage that has increased recently due to acquisitions. Despite strong recent revenue growth aided by Paycor integration, concerns around organic growth deceleration and macroeconomic pressures temper the outlook. Market sentiment is cautious with a consensus hold rating and a price target reflecting limited near-term upside cushioning against macro and regulatory risks.
Liquidity & Solvency
Current Ratio
Latest Quarter: Q1 2026
Quick Ratio
Latest Quarter: Q1 2026
Debt-to-Equity
Latest Quarter: Q1 2026
Debt-to-Assets
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Liquidity Metrics | ||||||||
| Current Ratio | 1.26 | 1.27 | 1.27 | 1.28 | 1.39 | 1.39 | 1.38 | 1.37 |
| Quick Ratio | 1.26 | 1.27 | 1.27 | 1.28 | 1.39 | 1.39 | 1.38 | 1.37 |
| Solvency Metrics | ||||||||
| Debt-to-Equity | 1.25 | 1.30 | 1.26 | 1.22 | 0.21 | 0.22 | 0.23 | 0.23 |
| Debt-to-Assets | 0.29 | 0.30 | 0.30 | 0.30 | 0.08 | 0.08 | 0.08 | 0.08 |
Liquidity Assessment
Current Ratio: 1.26(Adequate)
Quick Ratio: 1.26(Strong)
The company has adequate liquidity but may face challenges in a downturn.
Solvency Assessment
Debt-to-Equity: 1.25(High)
Debt-to-Assets: 0.29(Low)
The company has relatively high debt levels, which may increase financial risk in economic downturns.
Frequently Asked Questions about PAYX
AI Answers: Common Questions About PAYX
Get AI-powered answers to the questions investors ask most about Paychex, Inc.
PAYX is trading at $85.57, near its 52-week low and below its historical P/E average (current P/E: 18.89), making valuation attractive for defensive investors. However, technicals are bearish and sentiment is cautious, so it is not an ideal entry point for new buyers until a technical or growth catalyst emerges.
There is no urgent reason to sell if you already own PAYX, as fundamentals remain strong and the business is stable. However, with technicals weak and no clear upside catalyst, adding to positions is not advised; consider trimming only if your risk tolerance is low or you need to rebalance.
The biggest risks are elevated leverage (debt/equity ~1.3), integration execution with Paycor, and macroeconomic headwinds that could impact payroll volumes and float revenue. Liquidity is adequate (current ratio 1.26), but not robust, and regulatory or tech disruption could pressure margins.
Immediate support is at $85.45, with downside risk to $82 if that fails; resistance is at $88. Analyst price targets have been revised downward, reflecting limited near-term upside—expect a trading range unless a catalyst emerges.
PAYX is fairly valued to slightly undervalued: P/E (18.89) is below its 10-year average, P/S is above sector but below historical highs, and EV/EBITDA is elevated but justified by margins and cash flow. The market is not pricing in a growth premium due to muted outlook.
Fundamentally, PAYX is very strong: gross margins >35%, operating margins >25%, ROE >35%, and recurring revenue from a sticky client base. Growth is steady but not accelerating, and leverage has increased post-acquisition, so balance sheet strength is somewhat reduced.
Technically, PAYX is bearish: it is at 52-week lows with high volume on declines, no confirmed reversal patterns, and likely trading below key moving averages. Wait for signs of stabilization or a technical base before considering entry.
Key catalysts to watch include the next earnings report (for signs of organic growth or margin improvement), progress on Paycor integration and AI-driven product enhancements, and any macroeconomic rebound in SMB hiring or interest rates.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.